By Associate Professor Marina Pajic

Journal articles

Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SAJR; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale A-L; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DTW; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt ANJ; Valdés-Mas R; Van Buuren MM; Van 'T Veer L; Vincent-Salomon A; Waddell N; Yates LR; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR, 2013, 'Erratum: Signatures of mutational processes in human cancer', Nature, 502, pp. 258 - 258, http://dx.doi.org/10.1038/nature12666

Chang DK; Jamieson N; Johns A; Scarlett CJ; Pajic M; Biankin AV; et A, 2013, 'Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater', Journal of Clinical Oncology, 31, pp. 1348 - 1356, http://dx.doi.org/10.1200/JCO.2012.46.8868

Harliwong I; Gudkov AV; De Ridder J; Burkhart CA; Knosel T; Rummele P; Pajic M; Sartorelli AC; van der Weyden L, 2012, 'Impact of intertumoral heterogeneity on predicting chemotheraphy response of BRCA1-deficient mammary tumors', Cancer Research, 72, pp. 2350 - 2361, http://dx.doi.org/10.1158/0008-5472.CAN-11-4201

Song S; Nones K; Miller DK; Harliwong I; Pinese M; Kassahn KS; Pajic M; Gill A; Johns A; Anderson ML; Holmes O; Leonard C; Taylor DF; Wood SA; Xu Q; Newell FS; Cowley MJ; Wu J; Wilson PJ; Fink L; Biankin AV; Waddell NJ; Grimmond S; Pearson JV, 2012, 'qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profiles', PLoS ONE, 7, pp. e45835, http://dx.doi.org/10.1371/journal.pone.0045835

Perez-Mancera P; Rust AG; van der Weyden L; Kristiansen GO; Kristiansen GO; Li A; Sarver AL; Silverstein KAT; Grutzmann R; Aust DE; Rummele P; Knosel T; Herd C; Stemple D; Kettleborough R; Brosnan JA; Li A; Richard GM; Knight S; Yu J; Stegeman S; Collier LS; Ten Hoeve JJ; De Ridder J; Klein A; Goggins M; Hruban R; Chang D; Biankin AV; Pinese M; Grimmond S; Wessels L; Wood S; Iacobuzio-donahue CA; Pilarsky CP; Largaespada DA; Adams DJ; Tuveson DA; Rooman I; Pavey D; Cosman P; Nagrial A; Merrett N; asghari R; Cowley M; Daly R; Musgrove E; Pajic M; Wu J; Chang D; Chantrill L; Sutherland R; Gill A; Mawson A; Chou A; Kaplan W; Toon CCW; Johns A, 2012, 'The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma', Nature, 486, pp. 266 - 270, http://dx.doi.org/10.1038/nature11114

Chang DK; Colvin EK; Scarlett CJ; Pajic M; Pinese M; Gill AJ; Musgrove EA; Sutherland R; Kench J; Biankin AV, 2011, 'A molecular prognostic nomogram for resectable pancreatic cancer', JOURNAL OF CLINICAL ONCOLOGY, 29, http://dx.doi.org/10.1200/jco.2011.29.4_suppl.154

Chang DK; Johns A; Scarlett CJ; Pajic M; Chou A; Toon C; Samra JS; Sutherland R; Gill AJ; Biankin AV, 2011, 'Molecular pathologic phenotypes and outcome in adenocarcinoma of the ampulla of Vater', JOURNAL OF CLINICAL ONCOLOGY, 29, http://dx.doi.org/10.1200/jco.2011.29.4_suppl.196

Chang DK; Colvin EK; Scarlett CJ; Pajic M; Pinese M; Gill AJ; Musgrove EA; Sutherland R; Kench J; Biankin AV; New South Wales Pancreatic Cancer Network , 2011, 'A molecular prognostic nomogram for resectable pancreatic cancer.', J Clin Oncol, 29, pp. 154, http://www.ncbi.nlm.nih.gov/pubmed/27985628

Chang DK; Johns A; Scarlett CJ; Pajic M; Chou A; Toon C; Samra JS; Sutherland R; Gill AJ; Biankin AV; New South Wales Pancreatic Cancer Network , 2011, 'Molecular pathologic phenotypes and outcome in adenocarcinoma of the ampulla of Vater.', J Clin Oncol, 29, pp. 196, http://www.ncbi.nlm.nih.gov/pubmed/27985359

Scarlett CJ; Chang DK; Stoddart ES; Colvin EK; Mawson A; Jones MD; Tobelmann PE; Pajic M; Daly RJ; Biankin AV, 2010, 'High S100A2 Calcium-Binding Protein Expression Defines a Metastatic Phenotype in Pancreatic Cancer', PANCREAS, 39, pp. 1345 - 1346, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282946600205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chang D; Johns A; Scarlett C; Pajic M; Chou A; Jones M; Samra J; Henshall S; Musgrove E; Sutherland R; Gill A; Biankin A, 2010, 'Histology and Molecular Pathology Define Clinically Relevant Phenotypes in Carcinoma of the Ampulla of Vater', PANCREAS, 39, pp. 1313 - 1314, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282946600067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pajic M; Kersbergen A; Van Diepen F; Pfauth A; Jonkers J; Borst P; Rottenberg S, 2010, 'Tumor-initiating cells are not enriched in cisplatin-surviving BRCA1;p53-deficient mammary tumor cells in vivo', Cell Cycle, 9, pp. 3804 - 3815, http://dx.doi.org/10.4161/cc.9.18.13002

Zander SAL; Kersbergen A; Van Der Burg E; De Water N; Van Tellingen O; Gunnarsdottir S; Jaspers JE; Pajic M; Nygren AOH; Jonkers J; Borst P; Rottenberg S, 2010, 'Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecan', Cancer Research, 70, pp. 1700 - 1710, http://dx.doi.org/10.1158/0008-5472.CAN-09-3367

Rottenberg S; Pajic M; Jonkers J, 2010, 'Studying drug resistance using genetically engineered mouse models for breast cancer.', Methods in molecular biology (Clifton, N.J.), 596, pp. 33 - 45, http://dx.doi.org/10.1007/978-1-60761-416-6_3

Borst P; Rottenberg S; Jonkers J; Zander S; Pajic M; Jaspers J, 2010, 'The contribution of ABC transporters to drug resistance in a realistic mouse mammary tumor model', Cancer Genetics and Cytogenetics, 203, pp. 64 - 64, http://dx.doi.org/10.1016/j.cancergencyto.2010.07.044

Pajic M; Iyer JK; Kersbergen A; Van Der Burg E; Nygren AOH; Jonkers J; Borst P; Rottenberg S, 2009, 'Moderate increase in Mdr1a/1b expression causes in vivo resistance to doxorubicin in a mouse model for hereditary breast cancer', Cancer Research, 69, pp. 6396 - 6404, http://dx.doi.org/10.1158/0008-5472.CAN-09-0041

Rottenberg S; Nygren AOH; Pajic M; Van Leeuwen FWB; Van Der Heijden I; Van Wetering KD; Liu X; De Visser KE; Gilhuijs KG; Van Tellingen O; Schouten JP; Jonkers J; Borst P, 2007, 'Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer', Proceedings of the National Academy of Sciences of the United States of America, 104, pp. 12117 - 12122, http://dx.doi.org/10.1073/pnas.0702955104

Chung S; Wei A; Connor DE; Webb GC; Molloy TJ; Pajic M; Diwan AD, 2007, 'Nucleus pulposus cellular longevity by telomerase gene therapy', Spine, 32, pp. 1188 - 1196

Pajic M; Norris MD; Cohn RJ; Haber M, 2005, 'The role of the multidrug resistance-associated protein 1 gene in neuroblastoma biology and clinical outcome', Cancer Letters, 228, pp. 241 - 246

Pajic M; Bebawy M; Hoskins JM; Roufogalis BD; Rivory LP, 2004, 'Effect of short-term morphine exposure on P-glycoprotein expression and activity in cancer cell lines', Oncology Reports, 11, pp. 1091 - 1095, http://dx.doi.org/10.3892/or.11.5.1091

Ivanovic V; Filipovic V; Pajic M; Santini A, 1987, 'Tertiary dentine formation in dogs' teeth in response to lining materials.', J Dent, 15, pp. 85 - 87, http://dx.doi.org/10.1016/0300-5712(87)90006-6

Back to profile page